Under-30s to be offered alternative to AstraZeneca COVID-19 vaccine after reports of rare blood clots

People under 30 are to be offered alternatives to the Oxford/AstraZeneca COVID-19 vaccine after the MHRA said evidence was 'firming up' of a link between the vaccine and extremely rare blood clots.

No causal connection has yet been established between the AstraZeneca COVID-19 vaccine and blood clots. | GETTY IMAGES
No causal connection has yet been established between the AstraZeneca COVID-19 vaccine and blood clots. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package